Skip to main content

and
  1. No Access

    Article

    Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis

    Recently, three published phase III trials highlighted the superiority of investigational drugs compared to placebo, thus leading to their approval in the second-line setting. We report here a MAIC of second-l...

    Andrea Casadei-Gardini, Lorenza Rimassa in Journal of Cancer Research and Clinical On… (2021)

  2. No Access

    Article

    Ursolic acid enhances autophagic clearance and ameliorates motor and non-motor symptoms in Parkinson’s disease mice model

    Protein aggregation and the abnormal accumulation of aggregates are considered as common mechanisms of neurodegeneration such as Parkinson’s disease (PD). Ursolic acid (UA), a natural pentacyclic triterpenoid ...

    Yeo** Bang, Yoonjung Kwon, Mihyang Kim, Soung Hee Moon in Acta Pharmacologica Sinica (2023)